Aurobindo Pharma receives tentative approval from USFDA

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated April 03, 2013 titled "Aurobindo Pharma receives tentative approval for Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Tablets". Aurobindo Pharma is pleased to announce that it is one of the first generics company to have received the tentative approval to manufacture and market its anti-AIDS combination drug Efavirenz / Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 600mg/200mg/300mg from the US Food & Drug Administration (USFDA).Source : BSE

Read all announcements in Aurobindo Pharm

Anda sedang membaca artikel tentang

Aurobindo Pharma receives tentative approval from USFDA

Dengan url

https://rokokkanker.blogspot.com/2013/04/aurobindo-pharma-receives-tentative.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Aurobindo Pharma receives tentative approval from USFDA

namun jangan lupa untuk meletakkan link

Aurobindo Pharma receives tentative approval from USFDA

sebagai sumbernya